Abstract
The development of the atherosclerosis is based on multifactorial causes. In addition to the traditional risk factors, gene polymorphisms can play a role in the disease. Therefore in this study we investigated whether the eNOS and MTHFR gene polymorphisms is associated with myocardial infarction and stroke in patients with or without diabetes. We have identified polymorphisms in the NOS 3 gene and one of these polymorphisms, Glu298→Asp, was found to be a major risk factor for carotid artery disease and myocardial infarction. Our results indicate that the MTHFR G677T allele is significantly associated with MI. MTHFR 677 G/T genotyping may be of clinical importance as a prognostic and therapeutic marker, although further studies are needed to substantiate this hypothesis.
Similar content being viewed by others
Abbreviations
- MTHFR:
-
methylentetrahydrofolate reductase
- eNOS:
-
endothelial nitric oxide synthetase
- CHD:
-
coronary heart disease
- CVD:
-
cardiovascular disease
- CAD:
-
carotis artery disease
- MI:
-
myocardial infarction
References
Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801–809
Boerwinkle E, Elsworth DL, Hallman DM, Biddinger A (1996) Genetic analysis of atherosclerosis: a research paradigm for the common disease. Hum Mol Genet 5:1405–1410
Pallaud C, Sass C, Zannad F, Siest G, Visvikis S (2001) APOC3, CETP, fibrinogen, and MTHFR are genetic determinants of carotid intima-media thickness in healthy men (the Stanislas cohort). Clin Genet 59:316–324
Jerrard-Dunne P, Markus HS, Steckel DA, Buehler A, von Kegler S, Sitzer M (2003) Early carotid atherosclerosis and family history of vascular disease: specific effects on arterial sites have implications for genetic studies. Arterioscler Thromb Vasc Biol 23:302–306
Davignon J, Ganz P (2004) Role of endothelial dysfunction in atherosclerosis. Circulation 109:27–32
Colombo MG, Paradossi U, Andreassi MG, Botto N, Manfredi S, Masetti S, Biagini A, Clerico A (2003) Endothelial nitric oxide synthase gene polymorphisms and risk of coronary artery disease. Clin Chem 49:389–395
Jeerooburkhan N, Jones LC, Bujac S, Cooper JA, Miller GJ, Vallance P, Humphries SE, Hingorani AD (2001) Genetic and environmental determinants of plasma nitrogen oxides and risk of ischemic heart disease. Hypertension 38:1054–1061
Marroni AS, Metzger IF, Souza-Costa DC, Nagassaki S, Sandrim VC, Correa RX, Rios-Santos F, Tanus-Santos JE (2005) Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase genetic polymorphisms. Nitric Oxide 12:177–182
Tanus-Santos JE, Desai M, Flockhart DA (2001) Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics 11:719–725
Casas Juan P, Bautista Leonelo E, Humphries Steve E, Hingorani Aroon D (2004) Endothelial Nitric Oxide Synthase Genotype and Ischemic Heart Disease. Circulation 09:1359–1365
Mazza A, Giugliano D, Motti C, Cortese C, Andreotti F, Marra G, Nulli A (2000) Glycemia, MTHFR genotype and low homocysteine in uncomplicated type 2 diabetic patients. Atherosclerosis 149:223–224
Selhub J, Jacques PF, Bostom AG, Agostino RB D, Wilson PW, Belanger AJ, Leary DH O, Wolf PA, Schaefer EJ, Rosenberg IH (1995) Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 332:286–291
Refsum H, Ueland PM, Nygard O, Vollset SE (1998) Homocysteine and cardiovascular disease. Ann Rev Med 49:31–62
Ueland PM, Refsum H, Shirley AA (2000) Beresford and Stein Emil Vollset. The controversy over homocysteine and cardiovascular risk1,2. American J Clin Nutr 72:324–332
Refsum H, Ueland PM, Nygard O, Vollset SE (1998) Homocysteine and cardiovascular disease. Ann Rev Med 49:31–62
Bova I, Chapman J, Sylantiev C, Korczyn AD, Bornstein NM (1999) The A677V methylenetetrahydrofolate reductase gene polymorphism and carotid atherosclerosis. Stroke 30:2180–2182
Pallaud C, Sass C, Zannad F, Siest G, Visvikis S (2001) APOC3, CETP, fibrinogen, and MTHFR are genetic determinants of carotid intima-media thickness in healthy men (the Stanislas cohort). Clin Genet 59:316–324
Passaro A, Vanini A, Calzoni F, Alberti L, Zamboni PF, Fellin R, Solini A (2001) Plasma homocysteine, methylenetetrahydrofolate reductase mutation and carotid damage in elderly healthy women. Atherosclerosis 157:175–180
Inamoto N, Katsuya T, Kokubo Y, Mannami T, Asai T, Baba S, Ogata J, Tomoike H, Ogihara T (2003) Association of methylenetetrahydrofolate reductase gene polymorphism with carotid atherosclerosis depending on smoking status in a Japanese general population. Stroke 34:1628–1633
Zuliani G, Volpato S, Mecocci P, Cherubini A (2000) The A677V MTHFR allele is not associated with carotid atherosclerosis in octogenarians. Stroke 31:990–991
Mazza A, Motti C, Nulli A, Marra G, Gnasso A, Pastore A, Federici G, Cortese C (2000) Lack of association between carotid intima-media thickness and methylenetetrahydrofolate reductase gene polymorphism or serum homocysteine in non-insulin-dependent diabetes mellitus. Metabolism 1949:718–723
Rossi GP, Cesari M, Zanchetta M, Colonna S, Maiolino G, Pedon L, Cavallin M, Maiolino P, Pessina AC (2003) The T-786C endothelial nitric oxide synthase genotype is a novel risk factor for coronary artery disease in Caucasian patients of the GENICA study. J Am Coll Cardiol 41:930–937
Alvarez R, Gonzalez P, Batalla A, Reguero JR, Iglesias-Cubero G, Hevia S, Cortina A, Merino E, Gonzalez I, Alvarez V, Coto E (2001) Association between the NOS3 (-786T/C) and the ACE (I/D) DNA genotypes and early coronary artery disease. Nitric Oxide 5:343–348
Cai H, Wilcken DE, Wang XL (1999) The Glu-298—> Asp (894G—> T) mutation at exon 7 of the endothelial nitric oxide synthase gene and coronary artery disease. J Mol Med 77:511–514
Hibi K, Ishigami T, Tamura K, Mizushima S, Nyui N, Fujita T, Ochiai H, Kosuge M, Watanabe Y, Yoshii Y, Kihara M, Kimura K, Ishii M, Umemura S (1998) Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction. Hypertension 32:521–526
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Szabó, G.V., Kunstár, A. & Acsády, G. Methylentetrahydrofolate Reductase and Nitric Oxide Synthase Polymorphism in Patients with Atherosclerosis and Diabetes. Pathol. Oncol. Res. 15, 631–637 (2009). https://doi.org/10.1007/s12253-009-9163-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12253-009-9163-z